Всичко важно за вас на едно място
Следете емисии: блогове, новини, RSS и още. Лесен начин да четете и наваксвате с избраното от вас съдържание.
Вземете FeederRSS емисии за Здраве
Най-следваните от потребителите на Feeder RSS емисии за Здраве, включително 衛生福利部疾病管制署, ファイザー株式会社:最新プレスリリース и MediciNova, Inc. Events. Копирайте URL адрес на емисия или ги следвайте безплатно във Feeder.
Свързани теми
RSS емисии за Клинични изпитвания RSS емисии за Медицински изследвания RSS емисии за Психично здраве RSS емисии за Психология RSS емисии за Обществено здраве RSS емисии за Фармацевтика RSS емисии за Онкология
Предложи редакцияOzempic (semaglutide) - Novo Nordisk A/S
Ozempic (Active substance: semaglutide) - EU number: EU/1/17/1251 - Marketing authorisation holder: Novo Nordisk A/S
MedRegs
News and updates from Medicines and Healthcare products Regulatory Agency
MedTech Europe
MedTech Europe is the European trade association representing the medical technology industries, from diagnosis to cure.
Wiley: Journal of Applied Clinical Medical Physics: Table of Contents
Table of Contents for Journal of Applied Clinical Medical Physics. List of articles from both the latest and EarlyView issues.
BfArM RSS-Feed: Medizinprodukte/Informationen über Risiken/Maßnahmen von Herstellern
Medizinprodukte/Informationen über Risiken/Maßnahmen von Herstellern als RSS-Feed des BfArM
ClinicalTrials.gov: Entresto | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Entresto | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: Rybelsus | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Rybelsus | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: Tirzepatide | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Tirzepatide | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: Omecamtiv mecarbil | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Omecamtiv mecarbil | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: Finerenone | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Finerenone | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: dapagliflozin | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: dapagliflozin | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: SGLT2 | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: SGLT2 | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: HM15211 | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: HM15211 | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: Efinopegdutide | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Efinopegdutide | Industry | Last update posted in the last 14 days
ClinicalTrials.gov: cagrilintide | Industry | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: cagrilintide | Industry | Last update posted in the last 14 days
Recently Published All categories
New contents from the website www.hma.eu. Category: Recently Published All categories
Public Health | Latest updates
Public Health | Medicinal products - Latest updates
ClinicalTrials.gov: cagrisema | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: cagrisema | Last update posted in the last 14 days
ClinicalTrials.gov: Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation, Suspended, Terminated, Withdrawn Studies | Interventional Studies | Finerenone | Bayer | Phase 2, 3 | Last update posted in the last 2 days
Studies found on ClinicalTrials.gov by a search of: Recruiting, Not yet recruiting, Active, not recruiting, Completed, Enrolling by invitation, Suspended, Terminated, Withdrawn Studies | Interventional Studies | Finerenone | Bayer | Phase 2, 3 | Last update posted in the last 2 days
ClinicalTrials.gov: Hidradenitis Suppurativa | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Hidradenitis Suppurativa | Last update posted in the last 14 days
Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology is a peer-reviewed journal for oncologists and affiliated health-care professionals. The journal delivers timely interpretations of key scientific developments in oncology and related areas of study. Nature Reviews Clinical Oncology is published monthly in print and online, and includes news, commentary and opinion pieces, and comprehensive reviews. Articles are subject to rigorous peer-review and/or review by in-house editors. Topics covered include epidemiology, screening, diagnosis, pathology, prevention, chemotherapy, radiotherapy, surgical oncology, medical oncology, targeted therapies, hormonal therapies, hematology, immunotherapy, imaging, palliative care, pediatric oncology, genetics and pharmacology.
ClinicalTrials.gov: Huntington's Disease | Last update posted in the last 14 days
Studies found on ClinicalTrials.gov by a search of: Huntington's Disease | Last update posted in the last 14 days